Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire

References

• CellaDBullingerMScottCBarofskyIClinical Significance Consensus Meeting GroupGroup versus individual approaches to understanding the clinical significance of difference or changes in quality of lifeMayo Clin Proc20027738439211936936
   PubMed Web of Science ®Google Scholar
• GuyattGOsobaDWuAWWyrwichKWNormanGRClinical Significance Consensus Meeting GroupMethods to explain the clinical significance of health status measuresMayo Clin Proc20027737138311936935
   PubMed Web of Science ®Google Scholar
• OsobaDKingMTInterpreting quality of life in individuals and groups: meaningful differencesFayersPMHaysRDAssessing quality of life in clinical trials: Methods and practice2nd edOxford, UKOxford University Press2005243257
   Google Scholar
• AaronsonNKAhmedzaiSBergmanBThe European Organization for Research and Treatment of Cancer : a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst1993853653768433390
   PubMed Web of Science ®Google Scholar
• CellaDFTulskyDSGrayGThe functional assessment of cancer therapy scale: development and validation of the general measureJ Clin Oncol19931135705798445433
   PubMed Web of Science ®Google Scholar
• LydickEEpsteinRSInterpretation of quality of life changesQual Life Res1993232212268401458
   PubMed Web of Science ®Google Scholar
• KingMTThe interpretation of scores from the EORTC quality of life questionnaireQual Life Res1996565555678993101
   PubMed Web of Science ®Google Scholar
• KingMTStocklerMRCellaDFMeta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-GJ Clin Epidemiol201063327028119716264
   PubMed Web of Science ®Google Scholar
• CohenJStatistical power analysis for the behavioural sciences2nd edHillsdale, NJLawrence Erlbaum1988
   Google Scholar
• NormanGRSloanJAWyrwichKWInterpretation of changes in health-related quality of life: the remarkable universality of half a standard deviationMed Care20034158259212719681
   PubMed Web of Science ®Google Scholar
• LandisJKochGThe measurement of observer agreement for categorical dataBiometrics197733159174843571
   PubMed Web of Science ®Google Scholar
• DeeksJHigginsJAltmanDAnalysing and presenting resultsHigginsJGreenSCochrane Handbook for Systematic Reviews of Interventions 4.2.6 [Updated Sep 2006]Chichester, UKJohn Wiley & Sons2006
   Google Scholar
• FollmanDElliottPSuhIICutlerJVariance imputation for overviews of clinical trials with continuous responseJ Clin Epidemiol19924577697731619456
   PubMed Web of Science ®Google Scholar
• HedgesLVOlkinIStatistical Methods for Meta-analysisOrlandoAcademic Press1985110
   Google Scholar
• YostKJEtonDTCombining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experienceEval Health Prof200528217219115851772
   PubMed Web of Science ®Google Scholar
• CellaDEtonDTLaiJSPetermanAHMerkelDECombining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scalesJ Pain Symptom Manage200224654756112551804
   PubMed Web of Science ®Google Scholar
• AuchterRMScholtensDAdakSWagnerHCellaDFMehtaMPQuality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology GroupInt J Radiat Oncol Biol Phys20015051199120611483329
   PubMed Web of Science ®Google Scholar
• EsperPMoFChodakGSinnerMCellaDPientaKJMeasuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrumentUrology19975069209289426724
   PubMed Web of Science ®Google Scholar
• Watkins-BrunerDScottCLawtonCRTOG’s first quality of life study-RTOG 90-20: a phase II trial of external beam radiation with etanidazole for locally advance prostate cancerInt J Radiat Oncol Biol Phys19953349019067591900
   PubMed Web of Science ®Google Scholar
• SchinkJCWellerEHarrisLSOutpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II study (E2E93)J Cancer200172155164
   Web of Science ®Google Scholar
• DemetriGDKrisMWadeJDegosLCellaDQuality of life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study – Procrit Study groupJ Clin Oncol19981610341234259779721
   PubMed Web of Science ®Google Scholar
• LangerCJManolaJBernadoPCisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications for Eastern Cooperative Oncology Group 5592, a randomized trialJ Natl Cancer Inst200294317318111830607
   PubMed Web of Science ®Google Scholar
• FallowfieldLGagnonDZagariMMultivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapyBr J Cancer200287121341135312454760
   PubMed Web of Science ®Google Scholar
• HahnEAGlendenningGASorensenMVQuality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low dose cytarabine: results from the IRIS studyJ Clin Oncol200321112138214612775739
   PubMed Web of Science ®Google Scholar
• EtonDTCellaDYostKJA combination of distribution – and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleJ Clin Epidemiol200457989891015504633
   PubMed Web of Science ®Google Scholar
• McQuellonRPThalerHTCellaDMooreDHQuality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group studyGynecol Oncol2006101229630416376417
   PubMed Web of Science ®Google Scholar
• SchwartzCEBodeRRepucciNBeckerJSprangersMAGFayersPMThe clinical significance of adaptation to changing health: a meta-analysis of response shiftQual Life Res20061591533155017031503
   PubMed Web of Science ®Google Scholar
• KleeMKingMMachinDHansenHA clinical model for quality of life assessment in cancer patients receiving chemotherapyAnn Oncol Adv Access20001112330
   Web of Science ®Google Scholar
• McCainNLZellerJMCellaDFUrbasskiPANovakRMThe influence of stress management training in HIV diseaseNurs Res19964542462538700659
   PubMed Web of Science ®Google Scholar
• AroraNKGustafsonDHHawkinsRPImpact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective studyCancer20019251288129811571745
   PubMed Web of Science ®Google Scholar
• GustafsonDHHawkinsRPingreeSEffect of computer support on younger women with breast cancerJ Gen Intern Med200116743544511520380
   PubMed Web of Science ®Google Scholar
• VelikovaGBoothLSmithABMeasuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trialJ Clin Oncol200422471472414966096
   PubMed Web of Science ®Google Scholar
• JaeschkeRJSingerJGuyattGMeasurement of health status: ascertaining the minimally clinically important differenceControl Clin Trials1989104074152691207
   PubMedGoogle Scholar
• SchünemannHJPuhanMGoldsteinRJaeschkeRGuyattGHMeasurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ)J Chron Obstruct Pulmon Dis2004218189
   Google Scholar